For research use only · Not for human or veterinary use · 21+ qualified researchers
Buy 2, Get 1 Free

WP-CGR

From $71.99 / vial

For in-vitro laboratory research use only. Not for human or veterinary use.

Reference compound: Cagrilintide · CAS 1415456-99-3. Lyophilized powder, 5 mg, 10 mg. Single vial, Buy-2-Get-1 3-pack, or 10-vial lab kit. For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.

Free Priority Mail shipping on orders over $149.00 · 1–3 business days
Orders confirmed by 2 PM CT ship the same business day · USPS Priority Mail 1–3 days
SKU: WP-CGR Category: Tags: ,

For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.

What WP-CGR is

Cagrilintide (NN9838, formerly AM833) is a long-acting, acylated analog of human amylin, a 37-amino-acid pancreatic hormone co-secreted with insulin. Sequence substitutions suppress the fibrillation that limits native amylin, and a C20 fatty-diacid provides albumin binding.

Mechanism described in the literature

Cagrilintide is described as a dual amylin and calcitonin receptor agonist (DACRA). Amylin receptors are heterodimers of the calcitonin receptor with receptor activity-modifying proteins (RAMP1–3); cagrilintide retains activity at these complexes and at the calcitonin receptor itself. The area postrema and other hindbrain nuclei are the focus of its central-signaling literature.

Research areas

  • Amylin and calcitonin receptor pharmacology (CTR/RAMP complexes)
  • Peptide fibrillation and formulation chemistry
  • Hindbrain satiety signaling
  • Co-agonism with GLP-1 receptor agonists (CagriSema literature)
  • Gastric-emptying and glucagon-suppression models

Specifications

Product code WP-CGR
Reference compound Cagrilintide
CAS number 1415456-99-3
Molecular formula C194H314N56O55S2
Molecular weight 4409.1 g/mol
Composition Long-acting acylated amylin analog (37 residues) with a C20 diacid; acetate salt
Form Lyophilized powder
Net content options 5 mg, 10 mg
Container 3 mL clear glass vial, crimped aluminum seal, flip-off cap
Storage Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake.
Intended use In-vitro laboratory research only

Sizes and packs

Single vial at list price · 3-Pack = Buy 2, Get 1 Free (exactly 2× list) · 10-Vial Lab Kit = 25% off list. Select the size and pack above; the price updates.

Handling and storage

Store sealed vials at -20 °C, protected from light and moisture. 2–8 °C is acceptable for short periods such as transit and receiving. Allow a cold vial to reach room temperature before opening to avoid condensation on the lyophilized cake.

Vials ship sealed, cushioned and with a desiccant pack in plain packaging. Each vial is labeled with the product code, net content and the research-use designation. A packing slip lists the product codes and quantities ordered.

Frequently asked questions

Who can order?
Qualified researchers aged 21+ purchasing for in-vitro laboratory research. You confirm this at site entry and again at checkout.

When does it ship?
Orders confirmed by 2 PM CT ship the same business day by USPS Priority Mail (1–3 business days). Free shipping on orders over $149. Tracking is emailed when the carrier scans the label.

Can I return it?
All sales are final. Items that arrive damaged or incorrect are replaced when reported with photos within 72 hours of delivery — see Shipping & Returns.

References

  1. Kruse T, Hansen JL, Dahl K, et al.. Development of Cagrilintide, a Long-Acting Amylin Analogue. Journal of Medicinal Chemistry 2021. doi:10.1021/acs.jmedchem.1c00565
  2. Lau DCW, Erichsen L, Francisco AM, et al.. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. The Lancet 2021. doi:10.1016/S0140-6736(21)01751-7
  3. Enebo LB, Berthelsen KK, Kankam M, et al.. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial. The Lancet 2021. doi:10.1016/S0140-6736(21)00845-X

This overview summarizes published literature about the reference compound and is provided for research context only. It is not a description of the properties, effects or uses of this product, which is supplied strictly for in-vitro laboratory research by qualified researchers. Nothing on this page is an instruction for preparation or use.

For in-vitro laboratory research use only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Sold to qualified researchers aged 21+.

Available sizes and packs

Weight N/A
Size

10 mg, 5 mg

Pack

Single vial, 3-Pack · Buy 2 Get 1 Free, 10-Vial Lab Kit

Launch offer — 15% off your first order with codeWELCOME15